Health Condition 1: M679- Unspecified disorder of synovium and tendon
Conditions
Interventions
Intervention1: Granisetron and Butrophanol: Group I -Granisetron 40mcg, Group II-Butorphanol group 0.01mg/kg. Patients were monitored for- grade of shivering, temperature, heart rate, oxygen saturatio
Sponsors
BLDEDUS Shri BM Patil medical college and research center Vijayapur
Eligibility
Inclusion criteria
Inclusion criteria: Age 20-60 years of both the sexes American Society of Anaesthesiologist (ASA) grade I and II Patients posted for lower abdominal and lower limb surgeries under spinal anaesthesia
Exclusion criteria
Exclusion criteria: Medical disorders like hypo or hyperthyroidism, morbid obesity drug allergy, compromised cardiopulmonary functions and neuromuscular diseases, cesareansection were excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| compare the efficacy, potency, response time, hemodynamic alterations and adverse effects of intravenously administered butorphanol and granisetron for relief of shivering in spinal anaesthesia.Timepoint: Within 1 minute Between 1to 3 minutes Between 3-5 minutes Between 5-10 minutes Between 10-20 minutes No relief at all | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects Nausea Vomiting Pruritus Sedation score (0/1/2/3) Bradycardia and hypotension Timepoint: Postoperatively till 24 hrs | — |
Countries
India
Contacts
Public ContactDr Pratibha S D
BLDEDUS Shri B M Patil medical college and research center
Outcome results
None listed